Steve Bannon denies rumors of a 2028 presidential bid, emphasizing his support for Trump's agenda over personal ambitions.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
Steve Bannon denies rumors of a 2028 presidential bid, emphasizing his support for Trump's agenda over personal ambitions.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.